Elisa Carra
Via L.B. Alberti, 2
Genoa, 16132, Italy
Genoa, 16132, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells.
Journal: Stem cell research & therapy
Published: January 24, 2017
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.
Journal: Cell cycle (Georgetown, Tex.)
Published: November 15, 2015
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current.
Journal: Oncotarget
Published: September 02, 2014
Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019.
Journal: International journal of cancer
Published: June 25, 2014
Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019.
Journal: International journal of cancer
Published: October 29, 2013
NAC, tiron and trolox impair survival of cell cultures containing glioblastoma tumorigenic initiating cells by inhibition of cell cycle progression.
Journal: PloS one
Published: July 02, 2013
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.
Journal: Cell cycle (Georgetown, Tex.)
Published: January 18, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026